OQRO

Feed News

Explore

Insider trades Fund holdings Congress trades Federal contracts

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Director exercised or converted 2,806 GILD derivative securities | OQRO

Insider trades

Insider trade

Director exercised or converted 2,806 GILD derivative securities

Traded Nov 26, 2025 · Filed Dec 1, 2025

GILGilead SciencesGILD

2,806
Shares · @ $81.00

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Nov 26, 2025
Reporting period: Not applicable
Filed with the SEC: Dec 1, 2025

DirectorOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001629885-25-000005

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Dec 1, 2025, 9:54 PM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

GILEAD SCIENCES, INC.

Issuer CIK

882095

Ticker

GILD

Reporting person

Kelly A. Kramer

Relationship

Director

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Nov 26, 2025

Transaction code

Shares / units

2,806

Price per share

$81.00

Acquired / disposed

Acquired (A)

Shares owned after

4,145

Ownership form

Direct

Amendment

Footnotes from the filing

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 27, 2025.

Around the same time

CEO sold ~$1.25M of Gilead Sciences

Scheduled in advance9mo ago

CFO sold ~$366K of Gilead Sciences

Scheduled in advance10mo ago

Officer sold ~$366K of Gilead Sciences

Scheduled in advance10mo ago